IRadimed Corp (NASDAQ:IRMD)
| 45.06 Delayed Data As of Sep 28 |  +1.11 / +2.53%Today’s Change | 26.00 Today|||52-Week Range 51.04 | +59.28% Year-to-Date |
Latest IRMD News | Press Releases
| Zacks.com featured highlights include NVIDIA, iRadimed, Perdoceo Education and Axcelis Technologies Sep 25 / Zacks.com - Paid Partner Content | Encompass Health (EHC) Up 41% in a Year: More Room for Growth? Sep 20 / Zacks.com - Paid Partner Content |
| 4 Top Profitable Stocks to Invest in Using Net Income Ratio Sep 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 43.94 |
| Today’s open | 44.13 |
| Day’s range | 44.13 - 45.27 |
| Volume | 17,266 |
| Average volume (3 months) | 34,839 |
| Market cap | $547.7M |
Data as of 3:59pm ET, 09/28/2023
Growth & Valuation
| Earnings growth (last year) | +35.19% |
| Earnings growth (this year) | +18.18% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +27.48% |
| P/E ratio | 38.8 |
| Price/Sales | 6.71 |
| Price/Book | 7.43 |
Competitors
Data as of 3:59pm ET, 09/28/2023
Financials
| Next reporting date | November 2, 2023 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $53.3M |
| Annual profit (last year) | $12.8M |
| Net profit margin | 24.07% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Winter Springs, Florida |
Forecasts
